Drug-Eluting Contact Lenses May Help Treat Glaucoma

This article originally appeared here.
Share this content:
Drug-Eluting Contact Lenses May Help Treat Glaucoma
Drug-Eluting Contact Lenses May Help Treat Glaucoma

TUESDAY, Aug. 30, 2016 (HealthDay News) -- Latanoprost-eluting contact lenses are effective at lowering intraocular pressure in a glaucoma model, according to an experimental study published online Aug. 29 in Ophthalmology.

Joseph Ciolino, M.D., an ophthalmologist at Massachusetts Eye and Ear and an assistant professor of ophthalmology at Harvard Medical School in Boston, and colleagues tested the effectiveness of latanoprost-eluting low-dose contact lenses (CLLO) in four monkeys with glaucoma. The drug-administering contact lenses have a medicated polymer film that slowly delivered latanoprost to the monkeys' eyes.

The team found that the CLLO reduced intraocular pressure as much as the daily ophthalmic solution version of the medication. And lenses that dispensed higher doses of the drug resulted in greater reduction of intraocular pressure than the eye drops.

"Instead of taking a contact lens and allowing it to absorb a drug and release it quickly, our lens uses a polymer film to house the drug, and the film has a large ratio of surface area to volume, allowing the drug to release more slowly," senior author Daniel Kohane, M.D., Ph.D., director of the Laboratory for Biomaterials and Drug Delivery at Boston Children's Hospital, said in a news release from the Massachusetts Eye and Ear Infirmary.

Two authors are named as inventors on a patent for the drug-eluting contact lens evaluated in this study.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Alzheimer's Mortality Up 55 Percent From 1999 to 2014

CDC: Alzheimer's Mortality Up 55 Percent From 1999 ...

More patients also dying at home, with the caregiving burden often falling on loved ones

Targeting ANGPTL3 Can Significantly Lower Cholesterol

Targeting <i>ANGPTL3</i> Can Significantly Lower Cholesterol

Two trials show promise for non-statin approach to cardiovascular disease prevention

Factors Raise Risk of Pregnancy-Related Stroke in Preeclampsia

Factors Raise Risk of Pregnancy-Related Stroke in Preeclampsia

Infections, clotting disorders, chronic hypertension all found to increase risk

is free, fast, and customized just for you!

Already a member?

Sign In Now »